Report #2893316

Received Apr 20, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 18 yrs
State: AK
Recovered: Unknown
Vaccinated: Apr 20, 2026
Onset: Apr 20, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNP	MENINGOCOCCAL CONJUGATE (PENMENVY)	GLAXOSMITHKLINE BIOLOGICALS	1	3S9XZ/B	IM / LA

Symptoms (1)

Product preparation issue

Symptom narrative

PENMENVYy is provided as a solution Meningococcal B to be mixed with a powder of MenACWY. The patient was only given the solution of Meningococcal B. The manufacturer, GSK was contacted and confirmed that the pt only got Meningococcal B. They said they could not make any recommendations and that the provider could. The provider decided we could offer MenQuafi to the patient to give her the MenACWY component. The patient then received MenQuafi. A case number is logged with GSK (withheld). - RN

Current illness

None known

Other medications

Aleve 220mg, as needed

Allergies

NKDA, NKA